Tagged with EG

access Healthcare should not be seen as an expenditure, but rather as an investment. Mexico’s former minister of health and current dean at the Harvard T.H. Chan School of Public Health discusses how Mexico is moving towards effective universal coverage, the challenges the system is facing and the issues that remain.…

regulatory Alejandro Luna and José Alfredo Sedano, lawyers at the leading legal firm of Santamarina y Steta, discuss the current legal challenges faced by companies in the pharmaceutical and healthcare sector in Mexico and urge for the amendment of the current regulatory framework. How was the healthcare and life science practice…

regulatory Santiago Garcia Belmonte, president of Biosidus, discusses how global regulatory trends are driving change in the Argentinian biotech industry, as well the new direction his firm has taken over the last five years. How would you describe the recent changes in the biotech market and the industries new direction? Things…

government A former health minister who has now been appointed to spearhead the National Cancer Plan speaks out about what has been keeping him busy and the importance of making the paradigm shift from ‘treatment’-orientated healthcare to prevention and early screening. Could you briefly introduce yourself?  I was born in 1940…

regulation The general manager of Algeria’s pharmaceuticals regulator narrates the founding and evolution of the institution, how it has been flexing its muscles with the withdrawal of no less than 17 products from the local market, and how the body has been selected to play a leading role in the WHO’s Expert Advisory Panel on…

government The leader of the commission for health in the Algerian parliament’s upper chamber speaks out about new legislation under review, identifies other shortcomings in the country’s healthcare system and even gives personal insights from her own career as a medical practitioner alongside her political activities. Can you please start by outlining the role…

government The national coordinator for Argentina’s ministry of health Plan Remediar discusses developing a professional management culture in the country’s public health centers, and the programs wider role in the public health system.   Would you begin by giving our readers a brief introduction to Plan Remediar, and the scope of…

IP Alicia Alvarez Berkenwald, Partner at the specialized intellectual property services firm Berken IP, gives an introduction to the Argentinian IP environment, common strategies used to bypass obstacles, and Berken IP’s role in helping increase IP awareness in Argentinian research institutions.   Could you give us an overview of the changes…

heparin The vice president of Laboratorio Tuteur highlights the position of his company as the leaders in specialty products in Argentina.   Could you please give us an historical overview of Laboratorio Tuteur S.A.C.I.F.I.A., a company with more than 40 years of history? Laboratorio Tuteur S.A.C.I.F.I.A. is a company based in Argentina…

Novo Nordisk The global COO of the multinational at the forefront of the fight against diabetes explains why the Algerian market is so strategically important and how the ‘made in Algeria’ brand would have real potential at the regional level if only the government would remove impediments to export. As COO of Novo…

doing business Insights from existing players on what to expect and how to succeed in Algeria today. “The key to being successful is to be direct and forthright with the Algerians themselves. Trust in them and they will certainly trust in you.” – Essam Farouk, CEO, El Kendi. “The pace of doing…

sales UCB has transformed into a specialty care pharma which focuses on bringing solutions to patients suffering from severe chronic diseases. The vice president and region head for Americas discusses how the company re-entered key markets in the Latin American space to drive future growth, how the company’s three flagships products…